Cyclosporin-A reduced the cytotoxicity of propranolol in HUVECs via p38 MAPK signaling

Propranolol (PROP) is a nonselective β-adrenergic receptor antagonist used to treat hypertension and cardiac arrhythmias. Oral administration of PROP has recently emerged as a new treatment modality for hemangiomas. However, the side effects of PROP at the cellular level have not been adequately des...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Zhong, Xie, Guanhao, Cui, Haowen, Yao, Zhi, Shao, Congxiang, Yuan, Weiquan, Chen, Bailing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797567/
https://www.ncbi.nlm.nih.gov/pubmed/35089188
http://dx.doi.org/10.1097/MD.0000000000028329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797567/
https://www.ncbi.nlm.nih.gov/pubmed/35089188
http://dx.doi.org/10.1097/MD.0000000000028329

Ejemplares similares